Azitra, Inc. (AZTR)
NYSEAMERICAN: AZTR · Real-Time Price · USD
0.9639
-0.0081 (-0.83%)
Sep 3, 2025, 11:46 AM - Market open

Company Description

Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases.

It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease.

The company also develops ATR-04, a genetically modified strain of S. epidermidis that is in Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease.

It has a collaboration with Bayer. The company was incorporated in 2014 and is based in Branford, Connecticut.

Azitra, Inc.
Azitra logo
CountryUnited States
Founded2014
IPO DateJun 16, 2023
IndustryBiotechnology
SectorHealthcare
Employees12
CEOFrancisco Salva

Contact Details

Address:
21 Business Park Drive
Branford, Connecticut 06405
United States
Phone203 646 6446
Websiteazitrainc.com

Stock Details

Ticker SymbolAZTR
ExchangeNYSEAMERICAN
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$5.00
CIK Code0001701478
CUSIP Number05479L203
ISIN NumberUS05479L2034
Employer ID46-4478536
SIC Code2834

Key Executives

NamePosition
Francisco D. SalvaPresident, Chief Executive Officer and Director

Latest SEC Filings

DateTypeTitle
Aug 29, 2025S-1General form for registration of securities under the Securities Act of 1933
Aug 29, 20258-KCurrent Report
Aug 20, 2025SCHEDULE 13GFiling
Aug 20, 20258-KCurrent Report
Aug 14, 2025SCHEDULE 13G/AFiling
Aug 11, 20258-KCurrent Report
Aug 11, 202510-QQuarterly Report
Jul 24, 2025424B3Prospectus
Jul 23, 2025EFFECTNotice of Effectiveness
Jul 18, 2025S-1General form for registration of securities under the Securities Act of 1933